Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114,331,829
-
Number of holders
-
145
-
Total 13F shares, excl. options
-
72,206,146
-
Shares change
-
-1,513,804
-
Total reported value, excl. options
-
$1,413,058,139
-
Value change
-
-$18,741,577
-
Put/Call ratio
-
67%
-
Number of buys
-
85
-
Number of sells
-
-63
-
Price
-
$19.57
Significant Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q4 2019
181 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q4 2019.
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) has 145 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72,206,146 shares
of 114,331,829 outstanding shares and own 63% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (11,216,809 shares), FMR LLC (6,885,583 shares), BlackRock Inc. (5,792,687 shares), VICTORY CAPITAL MANAGEMENT INC (4,229,154 shares), VANGUARD GROUP INC (3,124,769 shares), Casdin Capital, LLC (2,550,000 shares), STATE STREET CORP (2,384,132 shares), Grosvenor Holdings, L.L.C. (2,285,714 shares), FARALLON CAPITAL MANAGEMENT LLC (2,250,000 shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2,002,605 shares).
This table shows the top 145 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.